Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity

Withdrawn

Phase 3 Results N/A

Summary of Purpose

This is a long-term safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper limb spasticity. Trial Stopped: The study was withdrawn prior to enrollment due to corporate decision.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 August 2014.

1 Aug 2014 21 May 2014 1 May 2017 1 May 2017 1 Aug 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts